2023 ICD-10-CM Diagnosis Code C12

Malignant neoplasm of pyriform sinus

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
  • C12 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM C12 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of C12 - other international versions of ICD-10 C12 may differ.
Applicable To
  • Malignant neoplasm of pyriform fossa
Use Additional
Use Additional Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
  • code to identify:
  • exposure to environmental tobacco smoke (
    ICD-10-CM Diagnosis Code Z77.22

    Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic)

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    Applicable To
    • Exposure to second hand tobacco smoke (acute) (chronic)
    • Passive smoking (acute) (chronic)
    Type 1 Excludes
    Type 2 Excludes
    • occupational exposure to environmental tobacco smoke (Z57.31)
    Z77.22
    )
  • exposure to tobacco smoke in the perinatal period (
    ICD-10-CM Diagnosis Code P96.81

    Exposure to (parental) (environmental) tobacco smoke in the perinatal period

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Code on Newborn Record
    Type 2 Excludes
    • newborn affected by in utero exposure to tobacco (P04.2)
    • exposure to environmental tobacco smoke after the perinatal period (Z77.22)
    P96.81
    )
  • history of tobacco dependence (
    ICD-10-CM Diagnosis Code Z87.891

    Personal history of nicotine dependence

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Type 1 Excludes
    • current nicotine dependence (F17.2-)
    Z87.891
    )
  • occupational exposure to environmental tobacco smoke (
    ICD-10-CM Diagnosis Code Z57.31

    Occupational exposure to environmental tobacco smoke

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Type 2 Excludes
    • exposure to environmental tobacco smoke (Z77.22)
    Z57.31
    )
  • tobacco dependence (
    ICD-10-CM Diagnosis Code F17
    • F17 Nicotine dependence
      • F17.2 Nicotine dependence
        • F17.20 Nicotine dependence, unspecified
          • F17.200 Nicotine dependence, unspecified, uncomplicat...
          • F17.201 Nicotine dependence, unspecified, in remissio...
          • F17.203 Nicotine dependence unspecified, with withdra...
          • F17.208 Nicotine dependence, unspecified, with other ...
          • F17.209 Nicotine dependence, unspecified, with unspec...
        • F17.21 Nicotine dependence, cigarettes
          • F17.210 Nicotine dependence, cigarettes, uncomplicate...
          • F17.211 Nicotine dependence, cigarettes, in remission...
          • F17.213 Nicotine dependence, cigarettes, with withdra...
          • F17.218 Nicotine dependence, cigarettes, with other n...
          • F17.219 Nicotine dependence, cigarettes, with unspeci...
        • F17.22 Nicotine dependence, chewing tobacco
          • F17.220 Nicotine dependence, chewing tobacco, uncompl...
          • F17.221 Nicotine dependence, chewing tobacco, in remi...
          • F17.223 Nicotine dependence, chewing tobacco, with wi...
          • F17.228 Nicotine dependence, chewing tobacco, with ot...
          • F17.229 Nicotine dependence, chewing tobacco, with un...
        • F17.29 Nicotine dependence, other tobacco product
          • F17.290 Nicotine dependence, other tobacco product, u...
          • F17.291 Nicotine dependence, other tobacco product, i...
          • F17.293 Nicotine dependence, other tobacco product, w...
          • F17.298 Nicotine dependence, other tobacco product, w...
          • F17.299 Nicotine dependence, other tobacco product, w...
    F17.-
    )
  • tobacco use (
    ICD-10-CM Diagnosis Code Z72.0

    Tobacco use

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Applicable To
    • Tobacco use NOS
    Type 1 Excludes
    • history of tobacco dependence (Z87.891)
    • nicotine dependence (F17.2-)
    • tobacco dependence (F17.2-)
    • tobacco use during pregnancy (O99.33-)
    Z72.0
    )
The following code(s) above C12 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C12:
  • C00-D49
    2023 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
Approximate Synonyms
  • Cancer of the pyriform sinus
  • Primary malignant neoplasm of pyriform sinus
ICD-10-CM C12 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
  • 012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
  • 013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
  • 146 Ear, nose, mouth and throat malignancy with mcc
  • 147 Ear, nose, mouth and throat malignancy with cc
  • 148 Ear, nose, mouth and throat malignancy without cc/mcc

Convert C12 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
Code annotations containing back-references to C12:
  • Type 2 Excludes: C13
    ICD-10-CM Diagnosis Code C13

    Malignant neoplasm of hypopharynx

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Type 2 Excludes
    • malignant neoplasm of pyriform sinus (C12)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
ICD-10-CM Codes Adjacent To C12
C10.4 Malignant neoplasm of branchial cleft
C10.8 Malignant neoplasm of overlapping sites of oropharynx
C10.9 Malignant neoplasm of oropharynx, unspecified
C11 Malignant neoplasm of nasopharynx
C11.0 Malignant neoplasm of superior wall of nasopharynx
C11.1 Malignant neoplasm of posterior wall of nasopharynx
C11.2 Malignant neoplasm of lateral wall of nasopharynx
C11.3 Malignant neoplasm of anterior wall of nasopharynx
C11.8 Malignant neoplasm of overlapping sites of nasopharynx
C11.9 Malignant neoplasm of nasopharynx, unspecified
C12 Malignant neoplasm of pyriform sinus
C13 Malignant neoplasm of hypopharynx
C13.0 Malignant neoplasm of postcricoid region
C13.1 Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect
C13.2 Malignant neoplasm of posterior wall of hypopharynx
C13.8 Malignant neoplasm of overlapping sites of hypopharynx
C13.9 Malignant neoplasm of hypopharynx, unspecified
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
C14.0 Malignant neoplasm of pharynx, unspecified
C14.2 Malignant neoplasm of Waldeyer's ring
C14.8 Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.